5-34937431-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001012339.3(DNAJC21):c.544C>T(p.Arg182*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000211 in 1,613,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001012339.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJC21 | NM_001012339.3 | c.544C>T | p.Arg182* | stop_gained | Exon 5 of 12 | ENST00000648817.1 | NP_001012339.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152004Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250874Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135686
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461848Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727224
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152004Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74218
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
This sequence change creates a premature translational stop signal (p.Arg182*) in the DNAJC21 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAJC21 are known to be pathogenic (PMID: 27346687, 28062395). This variant is present in population databases (rs771063992, gnomAD 0.008%). This premature translational stop signal has been observed in individual(s) with DNAJC21-related conditions (PMID: 30755392). ClinVar contains an entry for this variant (Variation ID: 598950). For these reasons, this variant has been classified as Pathogenic. -
DNAJC21-related disorder Pathogenic:1
The DNAJC21 c.544C>T variant is predicted to result in premature protein termination (p.Arg182*). This variant has been reported in the homozygous state in an affected individual with a bone marrow failure syndrome (Ji et al 2019. PubMed ID: 30755392). This variant is reported in 0.0085% of alleles in individuals of Latino descent in gnomAD. Nonsense variants in DNAJC21 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Bone marrow failure syndrome 3 Pathogenic:1
This is a nonsense variant predicted to result in a premature stop codon at position 182 and likely results in an absent or disrupted protein product. It was found in the compound heterozygous state. It is not reported in gnomAD (v4.1.0) in the homozygous state. Biallelic pathogenic variants in DNAJC21 are reported in autosomal recessive bone marrow failure syndrome 3 (OMIM #617052). It was reported as pathogenic in ClinVar. It was reported in literature (PMID: 30755392). Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at